Zacks Investment Research on MSN

RARE rises on completion of rolling submission for AAV gene therapy

Shares of Ultragenyx Pharmaceutical RARE were up 15.5% yesterday following the completion of the rolling submission of a ...
Opinion

AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

Ultragenyx Pharmaceutical Inc.: Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
IPWatchdog

The Top 10 Patents of 2025: Ubiquitous 6G Connections, Auditable Blockchain Transactions and Pest-Resistant Transgenic Corn

With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...